Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TRAW US Equity

Traws Pharma, Inc.Health Care · Pharmaceutical Preparations · CIK 1130598 · FY ends Dec 31
$0.54
+0.00 (+0.00%)
USD · as of 2026-08-19 · marketstack
4 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Ikarian Capital, LLCsec.gov ↗
2026-08-148-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Squadron Capital Management LLCsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Sirenia Capital Management LPsec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Adage Capital Management, L.P.sec.gov ↗
2026-07-318-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-07-108-K 8.01Other eventssec.gov ↗
2026-07-098-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-098-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-09

Every row is a filed document, checked against its EDGAR index.